loading...

Ocular Surface Disease Index (OSDI)

Walt JG; Rowe MM; Stern KL

ProQolid

Basic description

  • Developed in 1997
Authors

Walt JG; Rowe MM; Stern KL

Copyright
©1995, Allergan
Objective
To provide a rapid assessment of the range of ocular surface symptoms, including symptoms related to chronic dry eye, their severity, and their impact on the patient’s ability to function
Therapeutic area
  • Eye Diseases
Therapeutic indication
  • Eyelid Diseases
  • Corneal Diseases
  • Conjunctival Diseases
  • Lacrimal Apparatus Diseases
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the USA
Translations
28 translation(s)
Bibliographic reference(s) of the original questionnaire

Walt JG, Rowe MM, Stern KL. Evaluating the functional Impact of Dry Eye: The Ocular Surface Disease Index. Drug Information Journal 1997;31:1436

Walt JG, Rowe MM, Stern KL. Assessing the functional impact and severity of ocular surface disease using the ocular surface disease index (OSDI). Poster presentation at the 4th International Conference on the Lacrimal Gland, Tear Film, Ocular Surface and Dry Eye Syndromes: Basic Science and Relevance: Nov 11-20, 2004, Fajardo, Puerto Rico

Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000; 118:615-21 (Full text article)

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us